BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18449001)

  • 1. Improved treatment and survival for lung cancer patients in South-East Scotland.
    Erridge SC; Murray B; Price A; Ironside J; Little F; Mackean M; Walker W; Brewster DH; Black R; Fergusson RJ;
    J Thorac Oncol; 2008 May; 3(5):491-8. PubMed ID: 18449001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story?
    Erridge SC; Murray B; Williams L; Brewster D; Black R; Price A; Murray N; Sheehan F
    Lung Cancer; 2009 Jun; 64(3):358-66. PubMed ID: 19036470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in comorbidity and clinical management in patients newly diagnosed with lung cancer in four Scottish centers.
    Grose D; Devereux G; Brown L; Jones R; Sharma D; Selby C; Morrison DS; Docherty K; McIntosh D; Louden G; Downer P; Nicolson M; Milroy R;
    J Thorac Oncol; 2011 Mar; 6(3):500-9. PubMed ID: 21258251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
    Johnson AM; Hines RB; Johnson JA; Bayakly AR
    Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment.
    Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Louden G; Nicolson M; McMillan DC; Milroy R;
    Postgrad Med J; 2014 Jun; 90(1064):305-10. PubMed ID: 24676985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do multidisciplinary team meetings make a difference in the management of lung cancer?
    Boxer MM; Vinod SK; Shafiq J; Duggan KJ
    Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
    Soutar RL; Dawson AA; Wilson BJ
    Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N2 paradox: similar outcomes of pre- and postoperatively identified single-zone N2a positive non-small-cell lung cancer.
    Tsitsias T; Boulemden A; Ang K; Nakas A; Waller DA
    Eur J Cardiothorac Surg; 2014 May; 45(5):882-7. PubMed ID: 24080282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
    Stevens W; Stevens G; Kolbe J; Cox B
    Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.
    Cai XW; Xu LY; Wang L; Hayman JA; Chang AC; Pickens A; Cease KB; Orringer MB; Kong FM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1100-5. PubMed ID: 19540063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.